Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial

This publication has 13 references indexed in Scilit:

• Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis
  American Journal of Obstetrics and Gynecology, 1992
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial
  Journal of Clinical Endocrinology & Metabolism, 1992
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis
  American Journal of Obstetrics and Gynecology, 1992
• Bone Mass Reduction after Estrogen Deprivation by Long-Acting Gonadotropin-Releasing Hormone Agonists and Its Relation to Pretreatment Serum Concentrations of 1,25-Dihydroxyvitamin D₃
  Journal of Clinical Endocrinology & Metabolism, 1990
• Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients
  Fertility and Sterility, 1990
• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
  New England Journal of Medicine, 1988
• Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women: comparison of measurement methods.
  Radiology, 1986
• Revised American Fertility Society Classification of Endometriosis: 1985
  Fertility and Sterility, 1985
• Recurrent endometriosis: Incidence, management, and prognosis
  American Journal of Obstetrics and Gynecology, 1983
• Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
  American Journal of Obstetrics and Gynecology, 1981